Resource Type

Journal Article 2

Year

2019 2

Keywords

homoharringtonine 2

21) AML 1

AML1–ETO 1

acute myeloid leukemia 1

c-KIT 1

oridonin 1

pediatrics 1

synergistic effect 1

t(8 1

open ︾

Search scope:

排序: Display mode:

Homoharringtonine synergy with oridonin in treatment of t(8; 21) acute myeloid leukemia

Weina Zhang, Ying Lu, Tao Zhen, Xinjie Chen, Ming Zhang, Ping Liu, Xiangqin Weng, Bing Chen, Yueying Wang

Frontiers of Medicine 2019, Volume 13, Issue 3,   Pages 388-397 doi: 10.1007/s11684-018-0624-1

Abstract: Homoharringtonine (HHT) features activity against tumor cells harboring c-KIT mutations, whereas oridonin

Keywords: AML1–ETO     c-KIT     homoharringtonine     oridonin     t(8     21) AML     synergistic effect    

Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years

Xiaoxiao Chen, Yanjing Tang, Jing Chen, Ru Chen, Longjun Gu, Huiliang Xue, Ci Pan, Jingyan Tang, Shuhong Shen

Frontiers of Medicine 2019, Volume 13, Issue 3,   Pages 378-387 doi: 10.1007/s11684-018-0658-4

Abstract: Homoharringtonine (HHT), a plant alkaloid from , exhibits a unique anticancer mechanism and has beenConsequently, the homoharringtonine-based regimen achieved excellent EFS and alleviated hematologic toxicity

Keywords: homoharringtonine     acute myeloid leukemia     pediatrics    

Title Author Date Type Operation

Homoharringtonine synergy with oridonin in treatment of t(8; 21) acute myeloid leukemia

Weina Zhang, Ying Lu, Tao Zhen, Xinjie Chen, Ming Zhang, Ping Liu, Xiangqin Weng, Bing Chen, Yueying Wang

Journal Article

Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years

Xiaoxiao Chen, Yanjing Tang, Jing Chen, Ru Chen, Longjun Gu, Huiliang Xue, Ci Pan, Jingyan Tang, Shuhong Shen

Journal Article